{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:12:57Z","timestamp":1791987177079,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1006\/cimm.2000.1693","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T10:51:08Z","timestamp":1032173468000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell Lines"],"prefix":"10.1006","volume":"204","author":[{"given":"Dimitri","family":"Flieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Renoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Schmidt-Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/cimm.2000.1693_RF1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1006\/cimm.2000.1693_RF2","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1200\/JCO.1998.16.5.1788","article-title":"Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial","volume":"16","author":"Riethm\u00fcller","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/cimm.2000.1693_RF3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0609.1999.tb01725.x","article-title":"IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: Evaluation of response on 48 patients","volume":"62","author":"Nguyen","year":"1999","journal-title":"Eur. J. Haematol."},{"key":"10.1006\/cimm.2000.1693_RF4","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/cimm.2000.1693_RF5","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/cimm.2000.1693_RF6","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1073\/pnas.82.6.1766","article-title":"Role of the Bp35 cell surface polypeptide in human B-cell activation","volume":"82","author":"Clark","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/cimm.2000.1693_RF7","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.135.6.3795","article-title":"The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle","volume":"135","author":"Golay","year":"1985","journal-title":"J. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF8","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.4049\/jimmunol.138.10.3179","article-title":"Activation of human B cells: Alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells","volume":"138","author":"Smeland","year":"1987","journal-title":"J. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2141.1996.4781011.x","article-title":"CD20 and CD40 mediated mitogenic responses in B-lineage acute lymphoblastic leukaemia","volume":"93","author":"Smiers","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1006\/cimm.2000.1693_RF10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1074\/jbc.273.1.344","article-title":"Rapid redistribution of CD20 to a low density detergent-insoluble membrane compartment","volume":"273","author":"Deans","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1006\/cimm.2000.1693_RF11","doi-asserted-by":"crossref","first-page":"22632","DOI":"10.1074\/jbc.270.38.22632","article-title":"Association of 75\/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20: Evidence against involvement of the cytoplasmic regions of CD20","volume":"270","author":"Deans","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1006\/cimm.2000.1693_RF12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<65::AID-IMMU65>3.0.CO;2-E","article-title":"CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines","volume":"29","author":"Leveille","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF13","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/eji.1830221217","article-title":"Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40","volume":"22","author":"Valentine","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF14","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/eji.1830251126","article-title":"Engagement of CD20 suppresses apoptosis in germinal center B cells","volume":"25","author":"Holder","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1006\/cimm.2000.1693_RF16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644","article-title":"Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies","volume":"91","author":"Shan","year":"1998","journal-title":"Blood"},{"key":"10.1006\/cimm.2000.1693_RF17","first-page":"405a","article-title":"Anti-CD20 antibody mediated apoptosisis dependent on caspase 3 activation","volume":"92","author":"Mathas","year":"1998","journal-title":"Blood"},{"key":"10.1006\/cimm.2000.1693_RF18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/hyb.1999.18.63","article-title":"Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines","volume":"18","author":"Flieger","year":"1999","journal-title":"Hybridoma"},{"key":"10.1006\/cimm.2000.1693_RF19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002620050480","article-title":"The combination of interleukin-2 and interferon-\u03b1 effectively augments the antibody dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29","volume":"46","author":"Bungard","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/cimm.2000.1693_RF20","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood: Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"B\u00f6yum","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1006\/cimm.2000.1693_RF21","first-page":"4812","article-title":"Abnormal blood monocytes in chronic lymphocytic leukemia","volume":"48","author":"Flieger","year":"1988","journal-title":"Cancer Res."},{"key":"10.1006\/cimm.2000.1693_RF22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(94)00293-6","article-title":"A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells","volume":"180","author":"Flieger","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1006\/cimm.2000.1693_RF23","first-page":"840","article-title":"Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model","volume":"55","author":"Hooijberg","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/cimm.2000.1693_RF24","first-page":"4906","article-title":"Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies","volume":"49","author":"Press","year":"1989","journal-title":"Cancer Res."},{"key":"10.1006\/cimm.2000.1693_RF25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood.V83.5.1390.1390","article-title":"Retention of B-cell-specific monoclonal antibodies by human lymphoma cells","volume":"83","author":"Press","year":"1994","journal-title":"Blood"},{"key":"10.1006\/cimm.2000.1693_RF26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V81.6.1549.1549","article-title":"Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: An immunofluorescence and immunoelectron microscopy study","volume":"81","author":"Pulczynski","year":"1993","journal-title":"Blood"},{"key":"10.1006\/cimm.2000.1693_RF27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0145-2126(94)90092-2","article-title":"Modulation and intracellular transport of CD20 and CD21 antigens induced by B1 and B2 monoclonal antibodies in RAJI and JOK-1 cells\u2014An immunofluorescence and immunoelectron microscopy study","volume":"18","author":"Pulczynski","year":"1994","journal-title":"Leukocyte Res."},{"key":"10.1006\/cimm.2000.1693_RF28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1349-7006.1998.tb03280.x","article-title":"Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody","volume":"89","author":"Taji","year":"1998","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1006\/cimm.2000.1693_RF29","first-page":"A206","article-title":"Chimeric anti-CD20 antibody (IDEC-C2B8) is apoptotic and sensitizes drug resistant human B cell lymphomas and AIDS related lymphomas to the cytotoxic effect of CDDP, VP-16 and toxins","volume":"9","author":"Demidem","year":"1995","journal-title":"FASEB J."},{"key":"10.1006\/cimm.2000.1693_RF30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1023\/A:1008416911099","article-title":"Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma","volume":"9","author":"Berinstein","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1006\/cimm.2000.1693_RF31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0162-3109(96)00138-5","article-title":"Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin","volume":"35","author":"Benoit","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1006\/cimm.2000.1693_RF32","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1073\/pnas.94.14.7509","article-title":"Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells","volume":"94","author":"Ghetie","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/cimm.2000.1693_RF33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002371-199603000-00002","article-title":"Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas","volume":"19","author":"Funakoshi","year":"1996","journal-title":"J. Immunother. Emphasis Tumor Immunol."},{"key":"10.1006\/cimm.2000.1693_RF34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0008-8749(82)90208-8","article-title":"Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes","volume":"67","author":"Herberman","year":"1982","journal-title":"Cell. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF35","first-page":"6600","article-title":"Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma","volume":"47","author":"Munn","year":"1987","journal-title":"Cancer Res."},{"key":"10.1006\/cimm.2000.1693_RF36","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.4049\/jimmunol.138.10.3566","article-title":"Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies","volume":"138","author":"Ortaldo","year":"1987","journal-title":"J. Immunol."},{"key":"10.1006\/cimm.2000.1693_RF37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002620050245","article-title":"Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors","volume":"42","author":"Sahin","year":"1996","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/cimm.2000.1693_RF38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jcb.240450412","article-title":"Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity","volume":"45","author":"Liesveld","year":"1991","journal-title":"J. Cell Biochem."},{"key":"10.1006\/cimm.2000.1693_RF39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF00199217","article-title":"Granulocyte\u2013monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity","volume":"29","author":"Masucci","year":"1989","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/cimm.2000.1693_RF40","first-page":"2627","article-title":"Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2","volume":"55","author":"Hooijberg","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/cimm.2000.1693_RF41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jir.1992.12.345","article-title":"Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: A kinetic study","volume":"12","author":"Madsen","year":"1992","journal-title":"J. Interferon Res."},{"key":"10.1006\/cimm.2000.1693_RF42","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1821::AID-CNCR3>3.0.CO;2-Q","article-title":"Recombinant interferon-alpha therapy in patients with follicular lymphoma","volume":"82","author":"Ozer","year":"1998","journal-title":"Cancer"},{"key":"10.1006\/cimm.2000.1693_RF43","first-page":"A7","article-title":"Phase II pilot study of the safety and efficacy of rituximab in combination with CHOP chemotherapy in patients with previously untreated intermediate- or high-grade NHL","volume":"17","author":"Link","year":"1998","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1006\/cimm.2000.1693_RF44","first-page":"A39","article-title":"Combination immunotherapy of low grade or follicular (LG\/F) non-hodgkins lymphoma with rituximab, an alpha interferon: Interim analysis","volume":"17","author":"Davis","year":"1998","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1006\/cimm.2000.1693_RF45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/312641a0","article-title":"Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells","volume":"312","author":"Mingari","year":"1984","journal-title":"Nature"},{"key":"10.1006\/cimm.2000.1693_RF46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0145-2126(89)90004-0","article-title":"Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta","volume":"13","author":"Moberts","year":"1989","journal-title":"Leukocyte Res."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874900916939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874900916939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:30:52Z","timestamp":1757802652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874900916939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0008874900916939"],"URL":"https:\/\/doi.org\/10.1006\/cimm.2000.1693","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell Lines","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/cimm.2000.1693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}